NRXP NRx Pharmaceuticals, Inc.

NASDAQ
$2.15

NRx Pharmaceuticals, Inc. (NRXP) Institutional Ownership

What the institutions did with NRXP last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to.

Managers compared
36
filed both this quarter and last
Managers holding
29
-1 on the quarter
Buyers
19
6 opened new
Sellers
12
7 sold out entirely
Buyer share
61.3%
of managers who traded it
Breadth
+22.6
net buyers, as a share of those trading

The holder-level breakdown isn't available right now. The quarter's activity above is unaffected.

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.